Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
505.00    4.50 (0.90%)
Bid:
505.00
Ask:
505.50
Spread: 0.50 (0.099%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Result of AGM

25 Jul 2024 14:00

RNS Number : 8901X
Tate & Lyle PLC
25 July 2024
 

Tate & Lyle PLC

 

Result of Annual General Meeting 2024

 

Tate & Lyle PLC (the 'Company') announces that at its Annual General Meeting ('AGM') held earlier today, all resolutions contained in the Notice of Annual General Meeting 2024 issued on 4 June 2024, and the additional resolution number 23, (as per the revised proxy card announced on 21 June 2024) were duly passed.

 

The results of the poll held at the AGM are as follows:

 

 

Resolution

Total For(1)

Total Against

Votes withheld(2)

No. of votes

% of vote

No. of votes

% of vote

No. of votes

1.

Report and Accounts

300,021,820

99.95

152,354

0.05

1,028,695

2.

Directors' Remuneration Report

285,728,372

94.97

15,125,459

5.03

348,938

3.

Approve final dividend

301,024,943

99.95

147,865

0.05

30,061

4.

Elect David Hearn

279,830,226

92.93

21,281,056

7.07

91,487

5.

Re-elect Nick Hampton

265,830,412

88.48

34,605,956

11.52

766,401

6.

Re-elect Dawn Allen

267,294,959

88.78

33,775,274

11.22

132,536

7.

Elect Jeffrey Carr

281,604,927

93.52

19,504,200

6.48

93,642

8.

Re-elect John Cheung

263,591,452

87.54

37,521,609

12.46

89,708

9.

Re-elect Patrícia Corsi

276,627,915

91.87

24,490,399

8.13

84,455

10.

Elect Dr Isabelle Esser

276,630,982

91.87

24,487,414

8.13

84,373

11.

Re-elect Lars Frederiksen

277,084,070

92.02

24,029,469

7.98

89,230

12.

Re-elect Kimberly Nelson

277,800,567

92.26

23,319,115

7.74

83,087

13.

Re-elect Sybella Stanley

277,063,605

92.01

24,053,551

7.99

85,613

14.

Re-elect Warren Tucker

277,723,589

92.23

23,393,869

7.77

85,311

15.

Re-appoint Ernst & Young LLP

300,225,540

99.70

903,590

0.30

73,639

16.

Approve auditors' remuneration

300,969,108

99.94

178,317

0.06

55,344

17.

Authority to make political donations

296,529,201

98.50

4,520,562

1.50

153,006

18.

Authority to allot ordinary shares

283,586,997

94.17

17,553,950

5.83

61,822

19.

Authority to disapply pre-emption rights

295,678,656

98.20

5,405,016

1.80

119,097

20.

Additional authority to disapply pre-emption rights for an acquisition or specified capital investment

269,276,131

89.58

31,321,191

10.42

605,447

21.

Authority to purchase own shares

300,148,116

99.68

966,544

0.32

88,109

22.

Authority in respect of shorter notices for general meetings

292,322,062

97.07

8,818,454

2.93

62,253

23.

Permit the Board to change the name of the Company

300,291,457

99.73

816,925

0.27

93,530

 

 

(1) Includes discretionary votes.

 

(2) A 'vote withheld' is not a vote in law and is not counted in the calculation of the proportion of votes 'For' or 'Against' a resolution.

 

On 23 July 2024 there were 401,710,259 ordinary shares in issue, with 6,512,463 ordinary shares held in treasury, so the total voting rights were 395,197,796.

 

In accordance with Listing Rule 9.6.2, copies of the resolutions passed as special business at the AGM will shortly be available to view via the National Storage Mechanism at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

Claire-Marie O'Grady

Company Secretary

25 July 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPPUUAMUPCGPA
Date   Source Headline
27th Mar 20262:00 pmRNSHolding(s) in Company
13th Mar 20264:00 pmRNSHolding(s) in Company
2nd Mar 20262:00 pmRNSHolding(s) in Company
26th Feb 20267:00 amRNSTrading Statement
23rd Feb 202610:00 amRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSDirectorate change
15th Jan 20269:00 amRNSHolding(s) in Company
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
11th Dec 202512:18 pmRNSDirector/PDMR Shareholding
9th Dec 20259:00 amRNSHolding(s) in Company
27th Nov 202510:00 amRNSDirector/PDMR Shareholding
11th Nov 20254:30 pmRNSDirector/PDMR Shareholding
10th Nov 20252:40 pmRNSDirector Declaration
6th Nov 20257:00 amRNSHalf-year Financial Report
5th Nov 20252:15 pmRNSHolding(s) in Company
3rd Nov 20255:00 pmRNSHolding(s) in Company
29th Oct 20252:00 pmRNSHolding(s) in Company
23rd Oct 20254:15 pmRNSHolding(s) in Company
21st Oct 20253:30 pmRNSHolding(s) in Company
16th Oct 202512:00 pmRNSHolding(s) in Company
8th Oct 202512:00 pmRNSHolding(s) in Company
6th Oct 20254:30 pmRNSDirector/PDMR Shareholding
6th Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 202510:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSPre-close statement
2nd Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025
5th Jun 20252:00 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:30 pmRNSTotal Voting Rights
28th May 202512:00 pmRNSDirector/PDMR Shareholding
27th May 202512:00 pmRNSDirector/PDMR Shareholding
23rd May 202510:00 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSFinal Results
14th May 20259:00 amRNSHolding(s) in Company
1st May 20253:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.